P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.
The mouse mdr1a (also called mdr3) P-GP is abundant in the blood-brain barrier, and its absence in mdr1a (-/-) mice leads to highly increased levels of the drugs ivermectin, vinblastine, digoxin, and cyclosporin A in the brain. We show here that the drugs loperamide, domperidone, and ondansetron are...
Bewaard in:
| Gepubliceerd in: | J Clin Invest |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
1996
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507337/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8647944/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118699 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
